Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Top Business Leader to Chair Rosalind Franklin Institute

The Rosalind Franklin Institute
Posted on: 01 Sep 18

The Rosalind Franklin Institute has appointed one of the UK’s top business leaders to be its first Chair.

 

Dr. Vivienne Cox will lead the Board of the new national institute dedicated to bringing about transformative changes in life science through interdisciplinary research and technology development.

 

An experienced chairman and non-executive director in FTSE 100 companies, Vivienne has wide experience of creating and growing new businesses. Vivienne worked for BP plc for 28 years, in Britain and continental Europe, in posts including Executive Vice President and Chief Executive of BP’s gas, power and renewable business and its alternative energy unit. She also has a deep understanding of government, having been the Lead Independent Director of the UK Government's Department for International Development (DFID) for seven years.

 

A chemistry graduate with a passion for people and collaborative, interdisciplinary, ways of working, she will lead the development of the RFI Board – getting the right people in place, articulating a clear vision for the Institute, and establishing a strong strategic framework.

 

Professor Philip Nelson, EPSRC’s Executive Chair said: “Collaboration across disciplines, as well as between academia and industry, is critical to successful innovation. It is something the Engineering and Physical Sciences Research Council, as part of UK Research and Innovation, strongly encourages. Dr Vivienne Cox has an outstanding track record of leading multidisciplinary organisations and I welcome her appointment to this role”.

 

Professor Ian Walmsey, Pro-Vice-Chancellor Research & Innovation at the University of Oxford and Chair of the RFI’s Interim Board said:

 

“I am delighted that Vivienne has agreed to be the first Chair of the RFI. She brings deep experience of leading large-scale, multidisciplinary organisations, as well as strong connections to industry, and a strong belief in the mission of the Institute.”

 

Vivienne studied Chemistry at the University of Oxford then went on to a year’s research in Materials Science, before joining BP in the BP Chemicals business.

 

During her 28-year career at BP, Vivienne was regularly listed in Fortune magazine’s ‘World’s 50 Most Powerful Women in Business’ and won the Veuve Cliquot Business Woman of the Year award in 2007. Vivienne left BP in 2009 after leading BP’s Alternative Energy business which focused on wind, solar, biofuels and Carbon Capture and Storage (CCS) technologies as well as investing in new technology through a venturing unit.

 

Dr Vivienne Cox said:

 

“I have a passion for setting up new businesses and creating a culture of teamwork and collaboration. I’ve seen how siloed some parts of science and corporate R&D can be and relish the chance to break that down and bring university research and industry closer together.”

 

“The Industrial Strategy is clear that the UK needs to focus on areas where it has great competitive advantage. The exciting thing about the RFI is that it will harness our strengths in areas such as Artificial Intelligence and Robotics to dramatically improve our understanding of biology, leading to new diagnostics, new drugs, and new treatments for millions of patients Worldwide.”

 

Vivienne is currently a Non-Executive Director of GSK, Senior Independent Director of Pearson plc, a Non-Executive Director of Stena AB and Chairman of the Supervisory Board of Vallourec, a supplier to the energy industry. She was appointed Commander of the Order of the British Empire (CBE) in the 2016 New Year Honours for services to the UK Economy and Sustainability.

 

The Rosalind Franklin Institute

 

The RFI is an independent organisation funded by the UK government through the Engineering and Physical Sciences Research Council (EPSRC) and operated by ten UK universities.

 

It operates on a ‘hub and spokes’ model, with a central hub at the Harwell Campus in Oxfordshire, delivered by the Science and Technology Facilities Council (STFC). The hub, opening in 2020, will house a unique portfolio of scientific tools and researchers from both industry and academia. Equipment and researchers will also be located in spokes distributed throughout the partner network of universities.

 

The hub at Harwell is a four storey, £40m build, which is being project managed and delivered by STFC. With the façade of the building reflecting the iconic work of Rosalind Franklin, the hub will house the majority of the technologies produced for the Institute, and will have world leading capabilities in imaging and drug discovery, creating a globally unique centre of excellence in life science. It will be home to 150 researchers from industry and academia, working closely with neighbouring facilities at Harwell including the Diamond Light Source and STFC’s Central Laser Facility.

 

EPSRC and STFC are part of UK Research and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government.

 

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 01/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.